We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Corning (GLW) to Report Q3 Earnings: What's in the Cards?
Read MoreHide Full Article
Corning Incorporated (GLW - Free Report) is scheduled to report third-quarter 2020 results on Oct 27, before the opening bell. In the last reported quarter, the company delivered a positive earnings surprise of 127.3%. The bottom line surpassed the Zacks Consensus Estimate by 14 cents. Notably, Corning delivered a trailing four-quarter positive earnings surprise of 39.9%, on average.
The company is expected to have recorded slightly lower aggregate revenues year over year due to end-market challenges. Nonetheless, it continued to seek ways to leverage its deep technology, manufacturing and engineering capabilities to combat the COVID-19-related woes.
Factors at Play
During the quarter under review, Corning announced a collaboration with EnerSys — a leader in stored energy solutions for industrial applications — to speed up 5G deployment by simplifying the delivery of fiber and electrical power to small-cell wireless sites.
Corning introduced its newest breakthrough in glass technology, Gorilla Glass Victus. The glass significantly improves drop and scratch performance for the first time in the Gorilla Glass family, addressing consumer demand for improved durability.
These developments are likely to have aided the company’s performance. Corning expects third-quarter sales to grow in a low-teen percentage sequentially. Profitability growth is estimated to outpace sales growth as Corning’s cost-control efforts have enhanced operating leverage.
The Zacks Consensus Estimate for the Optical Communications segment’s net sales is pegged at $927 million. The figure indicates a fall of 7.9% from the year-ago quarter’s reported figure. The lower projection is due to the decline in the passive optical market. The consensus mark for Display Technologies net sales is $760 million, which suggests a decline of 4.2% from the prior-year quarter’s reported figure. This downside can be attributed to lower glass volume and prices.
The Zacks Consensus Estimate for Specialty Materials net sales is $539 million, which indicates growth of 16.4% year over year. The segment’s performance is likely to have been driven by strong demand for premium glasses, growth in IT products due to work- and study-from-home trends as well as demand for products in the semiconductor equipment space. The consensus estimate for Environmental Technologies is pegged at $333 million, which suggests a decline of 16.1%. This was a result of vehicle manufacturers’ suspended production in key markets. The Zacks Consensus Estimate for Life Sciences stands at $252 million, which suggests a slip from $256 million reported in the prior-year quarter.
For the September-ended quarter, the Zacks Consensus Estimate for revenues is pegged at $2,921 million, indicating a fall of 1.6%. Adjusted earnings per share are pegged at 36 cents, which suggests a decline of 18.2% year over year.
What Our Model Says
Our proven model doesn’t conclusively predict an earnings beat for Corning this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Corning’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is 0.00% as both are pegged at 36 cents.
Zacks Rank: Corning currently sports a Zacks Rank #1.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Century Communities (CCS - Free Report) is scheduled to release third-quarter 2020 results on Oct 28. The company has an Earnings ESP of +7.53% and a Zacks Rank #1.
Owens Corning (OC - Free Report) has an Earnings ESP of +12.46% and a Zacks Rank of 1. The company is set to report third-quarter 2020 results on Oct 28.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Corning (GLW) to Report Q3 Earnings: What's in the Cards?
Corning Incorporated (GLW - Free Report) is scheduled to report third-quarter 2020 results on Oct 27, before the opening bell. In the last reported quarter, the company delivered a positive earnings surprise of 127.3%. The bottom line surpassed the Zacks Consensus Estimate by 14 cents. Notably, Corning delivered a trailing four-quarter positive earnings surprise of 39.9%, on average.
The company is expected to have recorded slightly lower aggregate revenues year over year due to end-market challenges. Nonetheless, it continued to seek ways to leverage its deep technology, manufacturing and engineering capabilities to combat the COVID-19-related woes.
Factors at Play
During the quarter under review, Corning announced a collaboration with EnerSys — a leader in stored energy solutions for industrial applications — to speed up 5G deployment by simplifying the delivery of fiber and electrical power to small-cell wireless sites.
Corning introduced its newest breakthrough in glass technology, Gorilla Glass Victus. The glass significantly improves drop and scratch performance for the first time in the Gorilla Glass family, addressing consumer demand for improved durability.
These developments are likely to have aided the company’s performance. Corning expects third-quarter sales to grow in a low-teen percentage sequentially. Profitability growth is estimated to outpace sales growth as Corning’s cost-control efforts have enhanced operating leverage.
The Zacks Consensus Estimate for the Optical Communications segment’s net sales is pegged at $927 million. The figure indicates a fall of 7.9% from the year-ago quarter’s reported figure. The lower projection is due to the decline in the passive optical market. The consensus mark for Display Technologies net sales is $760 million, which suggests a decline of 4.2% from the prior-year quarter’s reported figure. This downside can be attributed to lower glass volume and prices.
The Zacks Consensus Estimate for Specialty Materials net sales is $539 million, which indicates growth of 16.4% year over year. The segment’s performance is likely to have been driven by strong demand for premium glasses, growth in IT products due to work- and study-from-home trends as well as demand for products in the semiconductor equipment space. The consensus estimate for Environmental Technologies is pegged at $333 million, which suggests a decline of 16.1%. This was a result of vehicle manufacturers’ suspended production in key markets. The Zacks Consensus Estimate for Life Sciences stands at $252 million, which suggests a slip from $256 million reported in the prior-year quarter.
For the September-ended quarter, the Zacks Consensus Estimate for revenues is pegged at $2,921 million, indicating a fall of 1.6%. Adjusted earnings per share are pegged at 36 cents, which suggests a decline of 18.2% year over year.
What Our Model Says
Our proven model doesn’t conclusively predict an earnings beat for Corning this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Corning’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is 0.00% as both are pegged at 36 cents.
Corning Incorporated Price and EPS Surprise
Corning Incorporated price-eps-surprise | Corning Incorporated Quote
Zacks Rank: Corning currently sports a Zacks Rank #1.
Stocks to Consider
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat this quarter:
Generac Holdings (GNRC - Free Report) is slated to release third-quarter 2020 results on Oct 28. It has an Earnings ESP of +4.70% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Century Communities (CCS - Free Report) is scheduled to release third-quarter 2020 results on Oct 28. The company has an Earnings ESP of +7.53% and a Zacks Rank #1.
Owens Corning (OC - Free Report) has an Earnings ESP of +12.46% and a Zacks Rank of 1. The company is set to report third-quarter 2020 results on Oct 28.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>